NEW YORK (GenomeWeb News) — 23andMe and Swiss company Mondobiotech will collaborate to offer researchers information about certain rare genetic diseases, the California consumer genomics firm said today.

The collaboration will use genetic information from individuals who suffer from diseases such as pulmonary arterial hypertension, sarcoidoisis, and pulmonary fibrosis. Mondobiotech will identify these patients and sponsor their enrollment in 23andMe's Personal Genome Service.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.